Results 161 to 170 of about 76,031 (377)

Misoprostol Versus Oxytocin for the Prevention of Postpartum Haemorrhage: A Systematic Review and Meta‐Analysis Including Individual Participant Data

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality. Uterotonics are the mainstay of PPH prevention. Objectives To compare the efficacy of misoprostol and oxytocin for the prevention of PPH and to evaluate the trustworthiness of these randomised controlled trials (RCTs).
Madeline Flanagan   +12 more
wiley   +1 more source

Recurrent Spontaneous Abortion

open access: yesInternational Journal of Immunopathology and Pharmacology, 1996
C. De Carolis   +4 more
openaire   +2 more sources

rDNA Copy Number Variation and Methylation During Normal and Premature Aging

open access: yesAging Cell, Volume 24, Issue 5, May 2025.
In > 160 healthy individuals the absolute rDNA copy number (CN) in blood ranged from approximately 240 to 900. The number of active copies with a completely unmethylated promoter varied from 40 to 120, independent of absolute CN. Promoter methylation is a compensation mechanism for absolute CN variation. Aging was associated with a loss of unmethylated
Alva B. C. Geisen   +5 more
wiley   +1 more source

مقایسه‌ی فراوانی ژنوتیپ Foxp3 در زنان با سقط مکرر خود به خود و افراد شاهد

open access: yesمجله دانشکده پزشکی اصفهان, 2013
مقدمه: سقط مکرر خود به خودی با از دست رفتن حاملگی دو بار یا بیشتر به صورت پشت سر هم قبل از هفته‌ی بیستم حاملگی؛ تعریف می‌شود. Foxp3 یک عامل نسخه‌برداری وابسته به سلول‌های T تنظیمی است که برای عملکرد این سلول‌ها ضروری است.
Narjes Abbasirad   +3 more
doaj  

Health Care for Dependents and Survivors of Veterans [PDF]

open access: yes, 2018
[Excerpt] The Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA) was established by the Veterans Health Care Expansion Act of 1973 (P.L. 93 82).
Panangala, Sidath Viranga
core   +1 more source

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage   +3 more
wiley   +1 more source

Planning postpartum contraception for women with substance use disorders: Utilisation of the birth admission

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
Background Women with substance use disorders (SUD) use less contraception, and experience higher rates of unintended pregnancy, compared to women without SUD. Contraception is discussed at the six‐week postnatal appointment, which many women with SUD do not attend.
Kelly A. McNamara   +6 more
wiley   +1 more source

Lack of association between the TGF-β1 gene polymorphisms and recurrent spontaneous abortion [PDF]

open access: yes
Transforming growth factor-β1 (TGF-β1) is produced by T regulatory lymphocytes (Treg), which play an important role in the physiology of pregnancy. Several polymorphisms of the TGF-β1 gene (TGFB1) have been reported, some with an important correlation
امانی, داور   +6 more
core  

Home - About - Disclaimer - Privacy